Kaku_2017_Expert.Opin.Drug.Saf_16_1313

Reference

Title : Safety evaluation of trelagliptin in the treatment of Japanese type 2 diabetes mellitus patients - Kaku_2017_Expert.Opin.Drug.Saf_16_1313
Author(s) : Kaku K
Ref : Expert Opin Drug Safety , 16 :1313 , 2017
Abstract : Kaku_2017_Expert.Opin.Drug.Saf_16_1313
ESTHER : Kaku_2017_Expert.Opin.Drug.Saf_16_1313
PubMedSearch : Kaku_2017_Expert.Opin.Drug.Saf_16_1313
PubMedID: 28829213

Related information

Citations formats

Kaku K (2017)
Safety evaluation of trelagliptin in the treatment of Japanese type 2 diabetes mellitus patients
Expert Opin Drug Safety 16 :1313

Kaku K (2017)
Expert Opin Drug Safety 16 :1313